PharmaDispatch is a paid subscription service.
Subscription options are available for individuals, small and large companies.
Individual subscriptions can be arranged for an annual fee of AUD$499 (plus GST).
PharmaDispatch offers a limited free trial. Email (firstname.lastname@example.org) for more information.
Subscriptions include immediate access to all website content, including daily news updates, opinion and analysis. It also entitles subscribers to re-purpose a PharmaDispatch analysis, such as for use in their own strategic or operational plans.
We have designed packages with wider use in mind. PharmaDispatch offers corporate packages starting with 5 user licenses. We will negotiate with individual organisations for tailored packages that include over 100 user licenses, or individual and confidential projects.
Subscriptions can be arranged directly at email@example.com or by calling 0408 492 937.
A short'ish history - the name gameSeptember 20, 2017 - Comment
MSD backs European naming systemSeptember 20, 2017 - Latest News
A new industry and innovation ministerSeptember 20, 2017 - Latest News
New MoU for MTPConnectSeptember 20, 2017 - Latest News
Sector battles it our over biologic namingSeptember 19, 2017 - Latest News
First day on the job for new secretariesSeptember 19, 2017 - Latest News
Government backs world first trial in childhood cancersSeptember 19, 2017 - Latest News